The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of huma
β¦ LIBER β¦
Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia
β Scribed by D. E. Joyner; T. A. Damron; A. Aboulafia; W. Bokor; J. D. Bastar; R. L. Randall
- Book ID
- 110892315
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 274 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0001-2815
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Heterogeneity in expression of human leu
β
Galen A. Ohnmacht; Francesco M. Marincola
π
Article
π
2000
π
John Wiley and Sons
π
English
β 218 KB
π 2 views
Heterogeneous expression of melanoma-ass
β
Janice N. Cormier; Yasmine M. Hijazi; Andrea Abati; Patricia Fetsch; Maria Betti
π
Article
π
1998
π
John Wiley and Sons
π
French
β 367 KB
π 2 views
MART-1/MelanA and Pmel17/gp100 are melanoma-associated antigens (MAAs) that can be recognized by tumorinfiltrating lymphocytes (TILs) capable of mediating successful adoptive therapy in vivo. Analysis of melanoma cell lines in vitro has demonstrated that heterogeneous antigen expression in the conte
2321 COMPARATIVE ANALYSIS OF PROSTATE CA
β
Quiles, M. Teresa; ArbΓ³s, Maria AntΓ²nia; de Torres, InΓ©s M.; BlΓ‘zquez, Carmen; B
π
Article
π
2011
π
Lippincott Williams and Wilkins
π
English
β 197 KB